Global Ketamine Therapy Market was Valued at US$ 1.38 Billion in 2022, Growing at an Estimated CAGR of 11.9% from 2023-2031

Ketamine therapy is a psychiatric treatment involving controlled administration of the anesthetic drug ketamine. Given in low doses, it’s used to alleviate symptoms of depression, anxiety, and certain mental health conditions. Its rapid effects and potential to target treatment-resistant cases make it a notable alternative in mental health care.

Intravenous (IV) ketamine therapy currently dominates the market due to its established efficacy and long-standing medical use. Surveys and studies consistently highlight the positive outcomes of IV ketamine in treating depression and certain mood disorders. Its direct administration into the bloodstream ensures rapid effects, making it a preferred choice.

COVID-19 Impact Analysis on Global Ketamine Therapy Market

Pre-COVID-19, the ketamine therapy market showed promise as a mental health treatment, with both intravenous and intranasal forms gaining traction. Post-COVID-19, the market adapted to pandemic challenges, with disruptions in healthcare access affecting patient reach. Telehealth gained prominence, but economic uncertainties impacted therapy availability and market dynamics.

Mental health professionals are seeking rapid relief through ketamine therapy stems owing to the pressing need to address treatment-resistant mental health disorders. Conventional treatments often take weeks to show results, leaving patients in distress. Recognizing the potential, psychiatrists, therapists, and other mental health providers are integrating ketamine therapy into their practices. Its rapid onset of action, often within hours, allows professionals to offer faster relief and symptom management for patients who may be in crisis or have exhausted traditional treatment options. This demand for innovative solutions aligns with ketamine therapy’s potential to reshape mental healthcare. A key restraint is the absence of standardized protocols and regulatory oversight. The lack of comprehensive regulations contributes to safety concerns and hesitancy among practitioners and patients, potentially limiting market growth.

Ketamine therapy significantly dominates the market for its effectiveness in treating depression. The therapy’s ability to provide quick and notable improvements in mood and overall well-being has positioned it as a leading choice for addressing depressive disorders.

North America dominated the global ketamine therapy market in 2022 due to its advanced healthcare infrastructure and early adoption. The US particularly leads in ketamine therapy integration, benefiting from a robust mental health industry and research initiatives.

Competitive Landscape: Global Ketamine Therapy Market

• AbbVie Inc.
• Actify Neurotherapies
• Janssen Pharmaceutical Companies (Johnson & Johnson Services, Inc.)
• Ketamine Clinics Los Angeles
• Ketamine Research Institute
• Ketamine Wellness Centers
• Klarisana
• Mindbloom, Inc.
• Neuro Wellness Spa
• Stella MSO LLC dba Field Trip Health
• Other Industry Participants

Global Ketamine Therapy Market Scope

Report Specifications	Details
Market Revenue in 2022	US$ 1.38 Billion
Market Size Forecast by 2031	US$ 3.74 Billion
Growth Rate (CAGR)	11.9%
Historic Data	2019 – 2021
Base Year for Estimation	2022
Forecast Period	2023 – 2031
Report Inclusions	Market Size & Estimates, Market Dynamics, Competitive Scenario, Trends, Growth Factors, Market Determinants, Key Investment Segmentation, Product/Service/Solutions Benchmarking
Segments Covered	By Type of Therapy, By Indication, By Setting, By Region
Regions Covered	North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Countries Covered	U.S., Canada, Mexico, Rest of North America,  France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe,  China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific,  Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa,  Brazil, Argentina, Rest of Latin America
Key Players	AbbVie Inc., Actify Neurotherapies, Janssen Pharmaceutical Companies (Johnson & Johnson Services, Inc.), Ketamine Clinics Los Angeles, Ketamine Research Institute, Ketamine Wellness Centers, Klarisana, Mindbloom, Inc., Neuro Wellness Spa, Stella MSO LLC dba Field Trip Health, Other Industry Participants
Customization Scope	Customization allows for the inclusion/modification of content pertaining to geographical regions, countries, and specific market segments.
Pricing & Procurement Options	Explore purchase options tailored to your specific research requirements
Contact Details	Consult With Our Expert Japan (Toll-Free):  +81 663-386-8111 South Korea (Toll-Free):  +82-808- 703-126 Saudi Arabia (Toll-Free):  +966 800-850-1643 United Kingdom: +44 753-710-5080 United States: +1 302-232-5106 E-mail:  [email protected]

Report Layout

Global Ketamine Therapy Market

By Type of Therapy

• Intravenous (IV) Ketamine Therapy
• Intranasal Ketamine Therapy
• Oral Ketamine Therapy

By Indication

• Depression
• Anxiety Disorders
• Chronic Pain
• Substance Use Disorders

By Setting

• Clinics
• Hospitals
• Others

By Region

• North America (U.S., Canada, Mexico, Rest of North America)
• Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
• Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
• Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
• Latin America (Brazil, Argentina, Rest of Latin America)

Table of Contents

.

.

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion

**Exclusive for Multi-User and Enterprise User.  

.

Global Ketamine Therapy Market

By Type of Therapy

By Indication

By Setting

By Region

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion

**Exclusive for Multi-User and Enterprise User.

The Niche Research approach encompasses both primary and secondary research methods to provide comprehensive insights. While primary research is the cornerstone of our studies, we also incorporate secondary research sources such as company annual reports, premium industry databases, press releases, industry journals, and white papers. Within our primary research, we actively engage with various industry stakeholders, conducting paid interviews and surveys. Our meticulous analysis extends to every market participant in major countries, allowing us to thoroughly examine their portfolios, calculate market shares, and segment revenues. Our data collection primarily focuses on individual countries within our research scope, enabling us to estimate regional market sizes. Typically, we employ a bottom-up approach, meticulously tracking trends in different countries. We analyze growth drivers, constraints, technological innovations, and opportunities for each country, ultimately arriving at regional figures.Our process begins by examining the growth prospects of each country. Building upon these insights, we project growth and trends for the entire region. Finally, we utilize our proprietary model to refine estimations and forecasts. Our data validation standards are integral to ensuring the reliability and accuracy of our research findings. Here's a breakdown of our data validation processes and the stakeholders we engage with during our primary research:

• Supply Side Analysis: We initiate a supply side analysis by directly contacting market participants, through telephonic interviews and questionnaires containing both open-ended and close-ended questions. We gather information on their portfolios, segment revenues, developments, and growth strategies.
• Demand Side Analysis: To gain insights into adoption trends and consumer preferences, we reach out to target customers and users (non-vendors). This information forms a vital part of the qualitative analysis section of our reports, covering market dynamics, adoption trends, consumer behavior, spending patterns, and other related aspects.
• Consultant Insights: We tap into the expertise of our partner consultants from around the world to obtain their unique viewpoints and perspectives. Their insights contribute to a well-rounded understanding of the markets under investigation.
• In-House Validation: To ensure data accuracy and reliability, we conduct cross-validation of data points and information through our in-house team of consultants and utilize advanced data modeling tools for thorough verification.

The forecasts we provide are based on a comprehensive assessment of various factors, including:

• Market Trends and Past Performance (Last Five Years): We accurately analyze market trends and performance data from preceding five years to identify historical patterns and understand the market's evolution.
• Historical Performance and Growth of Market Participants: We assess the historical performance and growth trajectories of key market participants. This analysis provides insights into the competitive landscape and individual company strategies.
• Market Determinants Impact Analysis (Next Eight Years): We conduct a rigorous analysis of the factors that are projected to influence the market over the next eight years. This includes assessing both internal and external determinants that can shape market dynamics.
• Drivers and Challenges for the Forecast Period:Identify the factors expected to drive market growth during the forecast period, as well as the challenges that the industry may face. This analysis aids in deriving an accurate growth rate projection.
• New Acquisitions, Collaborations, or Partnerships: We keep a close watch on any new acquisitions, collaborations, or partnerships within the industry. These developments can have a significant impact on market dynamics and competitiveness.
• Macro and Micro Factors Analysis:A thorough examination of both macro-level factors (e.g., economic trends, regulatory changes) and micro-level factors (e.g., technological advancements, consumer preferences) that may influence the market during the forecast period.
• End-User Sentiment Analysis: To understand the market from the end-user perspective, we conduct sentiment analysis. This involves assessing the sentiment, preferences, and feedback of the end-users, which can provide valuable insights into market trends.
• Perspective of Primary Participants: Insights gathered directly from primary research participants play a crucial role in shaping our forecasts. Their perspectives and experiences provide valuable qualitative data.
• Year-on-Year Growth Trend: We utilize a year-on-year growth trend based on historical market growth and expected future trends. This helps in formulating our growth projections, aligning them with the market's historical performance.

Research process adopted by TNR involves multiple stages, including data collection, validation, quality checks, and presentation. It's crucial that the data and information we provide add value to your existing market understanding and expertise. We have also established partnerships with business consulting, research, and survey organizations across regions and globally to collaborate on regional analysis and data validation, ensuring the highest level of accuracy and reliability in our reports.